• Explore /
  • Poster
  • / Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.

Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.

Abstract Video & Slides Poster

Authors

null

Howland E. Crosswell

Bon Secours Hematology Oncology, Bon Secours, St. Francis Health System, Greenville, SC

Howland E. Crosswell , Ann S. LaCasce , Nancy L. Bartlett , David J. Straus , Kerry J. Savage , Pier Luigi Zinzani , Graham P. Collins , Michelle A. Fanale , Keenan Fenton , Cassie Dong , Harry H. Miao , Andrew Grigg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Hodgkin Lymphoma

Clinical Trial Registration Number

NCT01712490

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 7528)

DOI

10.1200/JCO.2021.39.15_suppl.7528

Abstract #

7528

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Robert W. Chen

First Author: Stephen Maxted Ansell

First Author: Anas Younes

First Author: Scott F. Huntington